Home » Newsletters » BioWorld Science

BioWorld Science

Aug. 8, 2000

View Archived Issues

BioCryst strengthens drug candidate pipeline

Proteasome inhibitor PS-519 protective in cerebral ischemia model

GABA-B antagonist CGP-36742 promnestic in epilepsy model

NIH to conduct trials of potential new transplant therapy for diabetes

Incyte and Elitra establish antimicrobial genomics alliance

FDA approves Glucovance for treatment of type 2 diabetes

CRF1 receptor antagonist displays safety and efficacy in clinical trial

Research advances the use of transgenic plants to deliver vaccines

CGS-21680 promising agent for myocardial perfusion imaging

PR-000350 shows promise in improving efficacy of radiation therapy

Allovectin-7 phase I/II data released

Aventis seeks approval of Dynepo in U.S. and Europe

Icos and Array BioPharma expand collaboration

AMBI licenses nisin and lysostaphin to Biosynexus

Ginkgo biloba extract shows promise as treatment for dementia

Novel arylpiperazines assessed as uroselective agents for BPH

Once-daily postoperative dosing approved for Fragmin

Forest licenses dexloxiglumide from Rotta for treatment of IBS

New serine protease inhibitors useful for thromboembolic disorders

New serine protease inhibitors useful for treating cancer

New HIV integrase inhibitors under study at Merck & Co.

DNA topoisomerase II inhibitors under study at Lafon

New alpha4-integrin antagonists useful for asthma, etc.

New IL-5 inhibitors under development at Janssen

New antimicrobial agents under development at SmithKline Beecham

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 21, 2026.
Biohaven reports details on discovery of BHV-2100
BioWorld Science
Transient receptor potential melastatin 3 (TRPM3) is a calcium-permeable TRP channel that is highly expressed in somatosensory neurons, including nociceptors of...
Meta-analysis: Anti-amyloid Alzheimer’s drugs not ‘clinically meaningful’
BioWorld
The ongoing controversy over the effectiveness of anti-amyloid drugs is about to get more heated, after a review of clinical trials showed statistically...
New GABA(B) receptor PAMs revealed in Addex Pharma patents
BioWorld Science
Addex Pharma SA has disclosed new GABA(B) receptor positive allosteric modulators (PAMs) potentially useful for the treatment of chronic cough, urinary...
MMP inhibitors divulged in Accure Therapeutics patent
BioWorld Science
Accure Therapeutics has reported new oligopeptide derivatives acting as matrix metalloproteinase-2 (MMP-2) and MMP-9 inhibitors. As such, they are described as...